Skip to main content

MoneyWorks4Me

Wintac informs about quarterly statement on investor complaints

10 Oct 2016 Evaluate

Wintac has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended September 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1882.20
Dr. Reddys Labs. 1377.00
Cipla 1400.65
Lupin 2010.50
Zydus Lifesciences 1197.80
View more..